Schiller Medical Defigard Touch 7 - HSA Registration DE0019315
Access comprehensive regulatory information for Schiller Medical Defigard Touch 7 in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0019315 and owned by SCHILLER MEDICAL. The device was registered on June 14, 2017.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The DEFIGARD® Touch 7 defibrillation function is indicated for the treatment of ventricular fibrillation and pulseless ventricular tachycardia. Cardioversion in synchronised mode is indicated in the treatment of atrial fibrillation, atrial flutter, unstable patient with supraventricular tachycardia and some stable ventricular tachycardia. The defibrillation function can also be used for synchronised cardioversion of Atrial Fibrillation (AF) or ventricular arrhythmias. The DEFIGARD® Touch 7 pacemaker function can be used as an alternative to endocardial stimulation for the treatment of bradycardia. Depending on their configuration, the monitoring function of the DEFIGARD® Touch 7 delivers the most important parameters – ECG, SpO2, SpCO, SpMet, CO2, NIBP, IBP and Temperature and allows continuous monitoring of the patient from the beginning to the end of an intervention.